140 related articles for article (PubMed ID: 21077414)
21. Treatment efficacy of electromyography versus fiberscopy-guided botulinum toxin injection in adductor spasmodic dysphonia patients: a prospective comparative study.
Kim JW; Park JH; Park KN; Lee SW
ScientificWorldJournal; 2014; 2014():327928. PubMed ID: 25383369
[TBL] [Abstract][Full Text] [Related]
22. Workplace productivity and voice disorders: a cognitive interviewing study on presenteeism in individuals with spasmodic dysphonia.
Isetti D; Meyer T
J Voice; 2014 Nov; 28(6):700-10. PubMed ID: 24972537
[TBL] [Abstract][Full Text] [Related]
23. [Therapeutic difficulties in spasmodic dysphonia--case report].
Szkiełkowska A; Miaśkiewicz B; Baczyńska-Swierczyńska S; Szymańska E
Pol Merkur Lekarski; 2006 May; 20(119):557-9. PubMed ID: 16875162
[TBL] [Abstract][Full Text] [Related]
24. [Indications for botulinum toxin in laryngectomy].
Klap P; Marion MH; Perrin A; Fresnel-Elbaz E; Cohen M
Rev Laryngol Otol Rhinol (Bord); 1993; 114(4):281-7. PubMed ID: 8029549
[TBL] [Abstract][Full Text] [Related]
25. Current practices in the management of adductor spasmodic dysphonia.
Eskander A; Fung K; McBride S; Hogikyan N
J Otolaryngol Head Neck Surg; 2010 Oct; 39(5):622-30. PubMed ID: 20828529
[TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
[TBL] [Abstract][Full Text] [Related]
27. [Patterns of spasmodic dysphonia and botulinum toxin injections].
Xu W; Han DM; Hou LZ; Zhang L; Gao YH; Ye JY; Wang J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Apr; 40(4):253-7. PubMed ID: 16008256
[TBL] [Abstract][Full Text] [Related]
28. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings.
Zwirner P; Murry T; Swenson M; Woodson GE
Laryngoscope; 1992 Apr; 102(4):400-6. PubMed ID: 1556889
[TBL] [Abstract][Full Text] [Related]
29. Voice analysis in adductor spasmodic dysphonia: Objective diagnosis and response to botulinum toxin.
Suppa A; Asci F; Saggio G; Marsili L; Casali D; Zarezadeh Z; Ruoppolo G; Berardelli A; Costantini G
Parkinsonism Relat Disord; 2020 Apr; 73():23-30. PubMed ID: 32222482
[TBL] [Abstract][Full Text] [Related]
30. Life Threatening Delayed Complication of Botulinum Toxin Injection for Treatment of Spasmodic Dysphonia.
Yershov D; Partridge R
Prague Med Rep; 2020; 121(2):114-117. PubMed ID: 32553095
[TBL] [Abstract][Full Text] [Related]
31. Validation of the OMNI vocal effort scale in the treatment of adductor spasmodic dysphonia.
Shoffel-Havakuk H; Marks KL; Morton M; Johns MM; Hapner ER
Laryngoscope; 2019 Feb; 129(2):448-453. PubMed ID: 30315575
[TBL] [Abstract][Full Text] [Related]
32. [Treatment efficacy of electronic endoscope-guided botulinum toxin injection in adductor spasmodic dysphonia patients].
Ren J; Yang H; Wang H; Zou J; Lv D; Yu L; Zheng Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Nov; 34(11):1019-1023. PubMed ID: 33254323
[No Abstract] [Full Text] [Related]
33. Quality of Life After Botulinum Toxin Injection in Patients With Adductor Spasmodic Dysphonia; a Systematic Review and Meta-analysis.
Faham M; Ahmadi A; Silverman E; Harouni GG; Dabirmoghaddam P
J Voice; 2021 Mar; 35(2):271-283. PubMed ID: 31477348
[TBL] [Abstract][Full Text] [Related]
34. A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia.
Maloney AP; Morrison MD
J Otolaryngol; 1994 Jun; 23(3):160-4. PubMed ID: 8064952
[TBL] [Abstract][Full Text] [Related]
35. Risk factors and demographics in patients with spasmodic dysphonia.
Schweinfurth JM; Billante M; Courey MS
Laryngoscope; 2002 Feb; 112(2):220-3. PubMed ID: 11889373
[TBL] [Abstract][Full Text] [Related]
36. Perceptual analyses of spasmodic dysphonia before and after treatment.
Cannito MP; Woodson GE; Murry T; Bender B
Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1393-9. PubMed ID: 15611398
[TBL] [Abstract][Full Text] [Related]
37. Comparative effectiveness of propranolol and botulinum for the treatment of essential voice tremor.
Justicz N; Hapner ER; Josephs JS; Boone BC; Jinnah HA; Johns MM
Laryngoscope; 2016 Jan; 126(1):113-7. PubMed ID: 26198384
[TBL] [Abstract][Full Text] [Related]
38. Ventricular dysphonia: clinical aspects and therapeutic options.
Maryn Y; De Bodt MS; Van Cauwenberge P
Laryngoscope; 2003 May; 113(5):859-66. PubMed ID: 12792323
[TBL] [Abstract][Full Text] [Related]
39. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia.
Liu TC; Irish JC; Adams SG; Durkin LC; Hunt EJ
J Otolaryngol; 1996 Apr; 25(2):66-74. PubMed ID: 8683655
[TBL] [Abstract][Full Text] [Related]
40. Botulinum Toxin Dosing Trends in Spasmodic Dysphonia Over a 20-year Period.
Namin AW; Christopher KM; Eisenbeis JF
J Voice; 2017 Jan; 31(1):107-110. PubMed ID: 27005439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
